LAURA MCMAHON: Open Payments
NPI 1609008796 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 50 payments from 13 companies in 2025. Trend: 2023 $685 · 2024 $794 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $227 |
| AstraZeneca Pharmaceuticals LP | 8 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Lilly USA, LLC | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Amgen Inc. | 3 | $56 |
| PFIZER INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
Products named: Ozempic, CAPLYTA, MOUNJARO, Wegovy, REXULTI, FARXIGA, SHINGRIX, ZENPEP.
Industry payments across CO — which companies pay providers there.
